Seeking Alpha


Send Message
View as an RSS Feed
View SBResident's Comments BY TICKER:
Latest  |  Highest rated
  • Dendreon: Bending the Infamous Cost Curve [View article]
    Your statement of Insurance Companies telling patients they will not pay for Provenge is 100% wrong. The issue is at hand are private practice doctors having to pay for the drug up front and worried it will take months to get reimbursed.

    Don't make up stuff. That's bad journalism.
    Aug 4, 2011. 03:34 PM | 3 Likes Like |Link to Comment
  • Dendreon News Could Limit Long-Term Upside [View article]
    You should probably have mentioned in your article that early testing of patients with off label use has strongly shown a significant improvement in administering Provenge earlier on in the disease and tests are ongoing to support this claim.
    If Provenge is approved for Off Label, the chances are relatively high, then this company can become one of the biggest blockbusters ever. Also might want to mention their pipleline drugs that also use the same technology as Provenge. If only one of these drugs becomes FDA approved, well, that should take care of any Provenge issues.
    Jul 8, 2011. 03:14 PM | 10 Likes Like |Link to Comment
  • Analyzing George Soros's Top Holdings (Part 1) [View article]
    Dendreon is a winning lottery ticket by this time next year if they are not bought out.
    Jul 6, 2011. 02:35 PM | Likes Like |Link to Comment
  • Dendreon Is Way Undervalued [View article]
    Thank you for clarifying. I believe anyone who does their own DD knows the true value of this company. That is why we will continue to witness the SHORT interest do whatever is possible to degrade this company. Dendreon has raised the bar so high in the fight against cancer that BP will have to make a legitimate offer of $125 for starters.
    Apr 21, 2011. 02:50 PM | 7 Likes Like |Link to Comment
  • Beyond Provenge: Dendreon Is Too Expensive for Value, Growth Investors [View article]
    FYI, do not forget about the recent court decision in favor for Doctor's to prescribe a "medicine" for off label use if that Doctor believes it is in the patients best interest. This opens the door to a larger market for Provenge.
    Apr 21, 2011. 11:14 AM | 7 Likes Like |Link to Comment
  • Beyond Provenge: Dendreon Is Too Expensive for Value, Growth Investors [View article]
    Another tool heard from the tool shed.
    Apr 21, 2011. 09:50 AM | 7 Likes Like |Link to Comment
  • Dendreon: A Pipeline That's the Envy of Big Pharma [View article]
    Great Article!
    Apr 4, 2011. 09:31 AM | 3 Likes Like |Link to Comment
  • No 'Shareholder Uprising' at Dendreon [View article]
    This has everything to do with shareholders who were caught NOT SELLING when the stock hit the 50's and road it all the way back down.
    Apr 4, 2011. 09:21 AM | 3 Likes Like |Link to Comment
  • Wednesday's Vote Will Determine Dendreon's Fate [View article]
    Another blogger whom did not do his homework before writing his story. WOW! Are we surprised here?
    Nov 17, 2010. 09:43 AM | Likes Like |Link to Comment
  • What Medicare Will Ask About Dendreon's Provenge [View article]
    Hello, did this also happen to Taxotera? You know, the other alternative poison that no patient wants to take? It would seem that Medicare would not want to pay for a drug that actually poisons the patient and makes their life a living hell>?
    Sep 28, 2010. 10:15 AM | 4 Likes Like |Link to Comment
  • NEJM Editorial Raises Questions About Dendreon’s Cancer Vaccine Study: Biotech's Latest Mishaps [View article]
    A little late to the party there pal. The story has already been beaten down. NEJM should be ashamed at what they printed.
    Aug 1, 2010. 07:54 PM | 6 Likes Like |Link to Comment
  • Dendreon: Yes, It Got FDA Approval, But Here's What It Did Wrong [View article]
    LOL LOL Michael I would rather you have said Congratulations instead of your negativity. But I guess you cannot speak since your foot is completely inside your mouth since your last article stating there would be no approval.
    Apr 30, 2010. 02:00 PM | 10 Likes Like |Link to Comment
  • Antigenics Should Emerge From Dendreon's Shadow Soon [View article]
    Hi Michael, I am anxiously awaiting your next article on Dendreon Post Approval.
    Apr 13, 2010. 09:30 AM | Likes Like |Link to Comment
  • Dendreon Still Faces 65 / 35 Odds of Provenge Approval [View article]
    Michael, can you inform your readers what medical degree you have to be able to write an article about such a complex drug like Provenge? Or are you just a journalist voicing your opinion on no medical background?
    Feb 24, 2010. 08:46 AM | 9 Likes Like |Link to Comment